“Sometimes one pays most for the things one gets for nothing.” ~ Albert Einstein
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They better,or netflix will stay the king.
Heres a good one...?...Those buying in at .12 might think they missed the boat, just as those buying in .50, in a while, might think they really missed the boat, and just as those that buy in at $1 think they really really missed the boat.
When it gets to several dollars, they will all realize that they really didn't miss the boat, unless, of course, if they sell prematurely. Those might miss the boat, but do so out their own choosing.
" Is this a truth."
This was said july 5 .........I really think .25 is going to be the next big resistance. I say we go up a little early mon drop to 10 percent red and finish at least 10 percent green. Dip won't last long like with most penny's. this one is real and people know it. Not letting go of the golden tickets we are holding on to. Next week we finish above .15 .........Will this ever happen ?
Don't really rember their handle,but it was said.A few times.Go back and read the older post.Also was said, was to hold,by some only to find out they sold.Seems like 100ks for some and over.Good for them,but small time people like me,i guess get to be what i here become bagholders.Many miss leading truths.How well they sleep is beyond me.Hope NTEK has a brighter road ahead.The truth is hard to accept for most,yet it effects everyone.So does the untruth.
Man alot of people here in july 3,4,5, said they were putting in a sell order @.99. so i bought 7k @.094 and now,their saying .04 or .03,.02.what the heck.Show me the money.Things are not looking good here.Also i read no one can say where this nuvola thing is made?Iam way DOWN.Thought the good long time investors Knew what was up.Keep saying hang on for a year.Looks like they sold out.My mother is very sick and was going to help her,with my NTEK investment.now iam out of money.Do you think it will go back up.HELP,Iam screwed.
Take your pick--10x or 20x? O let me think.....about this. Which one is 20x,let me guess........HHSE.
My ? is do you think,that other will shine,or will HHSE be the winner ?
I see in your profile some of the stocks you have,yet i do not see HHSE. Just not listed ? I see that other one,dont think the HUB will let me say.Lets see NTEK.
Where are all the buys,this thing wants to GO.and IS,SOON. I picked 100k yesterday.Where is your faith in this CO. JUST TALK.Words are cheep.I think we have very small time investors here NOW,and JUST WANT to SELL,for chump CHANGE.Thats why this wont move,goes up alittle and little sellers sell.LIFE IS TO SHORT TO BE SCARED.OR YOU WILL ALWAYS BE BROKE.
JUST BUY NOW, ITS A GREAT BUY.Go ahead and try to find another CO. in this price range,with NO DEBT.and all what they have in the works.Good luck to ya.
There is not going to be a big drop.This is a great entry point.Dont let this slip to far from your hands. INO has got the answer to fight cancer,and is not turning back.$1.47 for a game changer,yea .49 cent would be great,those days are over.
Why You Should Be Investing In DNA Vaccination Technology And Inovio Pharmaceuticals
May 16 2013, 11:38 about: INO (Inovio Pharmaceuticals Inc)
Disclosure: I am long INO.
Important Historical and Sociological perspective on current and future vaccination technology
Historically vaccines are thought of as one of the greatest achievements of modern medicine, as is shown by the eradication of Smallpox, near eradication of Polio, and the controlling of Hepatitis A/B, typhus, and rotavirus. However, certain major diseases still remain, such as HIV, Hepatitis C, and Malaria, diseases that if a vaccination were to be developed, would be monumental.
In a sociological perspective the human race has been proceeding into a new era following the successful deciphering of the human genome, an era centered on major biotechnological advances that will greatly impact our lives.
How do these perspective tie together?
Traditional vaccine are created by use of a live or weakened variation of the disease is introduced into a person and creates an immunity to the pathogen should the person be introduced to it in the future. While effective, these weakened vaccines carry a risk that the introduced pathogen can revert to its dangerous form and cause the disease in the vaccine recipient. A second form of traditional vaccination attempts to introduce a dead variation of the pathogen into the recipient to build an immunity, however they are ineffective at generating specific immune responses to many diseases.
With the recent decoding of the human genome we now understand and have the capability to advance medicine through the use of gene therapy, which has most recently been applied through the creation of a new vaccination method known as DNA vaccination.
In DNA vaccination a section of DNA that has been genetically engineered to produce an immunity to a disease is injected into the cells of the body, where the hosts body reads this DNA and uses it as a blueprint to create an immunity. This has been proven to be an incredibly safe method of vaccination as there is no weakened form of the virus being introduced to the vaccine recipient that is able to potentially revert to its dangerous form. It is also remarkably more effective as it can target multiple strains of a disease (such as influenza) instead of being developed for each concurrent strain as it mutates. While still under development for use in humans, DNA vaccines have most recently been approved for use in animals, specifically the treatment of infectious hematopoetic necrosic vaccine for salmon [Novartis (NVS)] and for West Nile Virus in Horses [Pfizer (PFE)].
One company, Inovio Pharmaceuticals (INO), is poised to take center stage in this new era with their role in the development of these DNA vaccines for humans, vaccines which are currently being developed towards treating many forms of Cancer, HIV, Hepatitis C, Leukemia, Malaria, and Influenz.
Electroporation
The most important patent is Inovio's own Electroporation technology which is essential to all DNA vaccines created in the future.
By applying an electrical current to the DNA vaccine site, the hosts cell membranes become 'porous and allow the DNA vaccine to enter the cells more effectively.
Financial
Inovio currently has a Market cap of $115 Million dollars, Inovio recently underwent a common offering of $15.1 million in stocks and warrants. Inovio has a total debt of $0, and there has also been extensive insider buying over the last several months.
old news,but still is true.Thats all that counts. Minimizing Risk When Investing In Biopharmas, one of the key criteria when considering to invest in a biopharma is to take a look at the staff that comprises it. Inovio's staff management is composed of strong scientific minds, with a vast history of vaccine development and discovery, and many with ties to big pharmaceutical corporations.
CEO Joseph Kim is an Ex-Merck (MRK) employee who worked on the development of HEP A/B, and HIV vaccine R&D.
David B. Weiner, PhD and Chairman is known as the "Father of DNA vaccines" and is a member of the Dept. of Pathology & laboratory Medicine, U of PA.
Philip Greenberg, MD is an expert in T-Cell Immunology and head of the Immunology Program, Fred Hutchinson Cancer Research Center.
Adel Mahmoud, PhD is a professor at Princeton University and a former President of Merck Vaccines responsible for Gardasil, Zostavax, Proquad, and Rotateq.
Anthony W. Ford-Hutchinson, PhD is also a former Senior VP of Merck vaccine R&D, and oversaw the development of Singulair, Januvia, Gardasill, Zostavax, Proquad, and Rotateq.
Stanley A. Plotkin, MD developed the Rubella and Rabies vaccine, and oversaw the Sanofi (SNY) flu vaccine.
Simon X. Benito is a former Senior VP of Merck Vaccine division.
Pipeline and Funding:
With a large pipeline, most of which have passed phase I clinical trials showing a best-in-class immune response, many important validating clinical milestones are expected very shortly over the next quarters, most within the first half of 2013.
It is important to note that the funding for these trials comes heavily from the sponsoring institutions, leaving Inovio with $0 in overall debt.
Third-party funding includes:
Bill and Melinda Gates are funding the preclinical development of Syncon synthetic vaccine for malaria
The HIV Vaccine Trial Network is providing $23.5 million in funding for Pennvax-B
The U.S. Military HIV Research Program (MHRP) is sponsoring Pennvax-G
The US Department of Homeland Security towards a Syncon vaccine for foot & mouth disease.
National Cancer Institute
Merck pharmaceuticals
Current Pipeline:
HIV - Pennvax-B / Pennvax-G
Best response in comparison to all other previously tested HIV vaccines with 88.9% (24 of 27 subjects) showing a positive immune response
Cervical Dysplasia (Run by INO)
Phase I showed a strong immune response in 78% (14 of 18 subjects) in one measurement, and 91% (10 of 11 subjects) in another
Of these, 92% (12 of 13 responders) displayed persistent immunization response to the end of the study 9 months later.
Influenza
Syncon, a universal vaccines for influenza stains is a major development as current vaccinations can only target single strains.
Syncon has shown to protect against all 6 unmatched H5N1 strains tested
Syncon has shown to protect against all 9 unmatched H1N1 strains tested
Significant development for the elderly population, who are those most at risk for flu deaths. Has shown to increase generation of infection preventing antibodies by 100%. (from 20% to 40% efficacy in the elderly)
Leukemia
Phase II Clinical results showed an immune response in all subjects who were
Many more targets are currently being added to the pipeline, to include: Malaria, Foot and Mouth Disease, Prostate Cancer, and Hep-C. On top of this, Inovio also has a large Patent pool with 424 patents issued or pending so far.
A scam,man their site,is very good.If this is all people can find wrong,we are in good shape.
Iam in Iam a small investor,just picked up 7k.@ 1.37...INO looks like they have been working long and hard,to help fight cancer,they deserve our respect.I have close family who are suffering from cancer.Pray INO has some drugs on the way.
hedge funds,dont buy poop.This is so over sold,.004 is its max.Than R/S 1 for 5000.
I dont belive people who say their loading. Their dumping.
I took the time,to read many of the past post,even as far back 2011,one long stock poop.It needs to climb out of this pit,and sell their products to the world,and prove they have life saving skills.All this talk is just talk.There are so many co.s in penny land,that cant do what they say they can do.But sell shares.And they get cheaper and cheaper.
The buying just keeps getting stronger.When they release news,of what is really going on,hang on its going to be a wild ride.SGLB will be talked about,for years to come.The suckers who sell now will be,needing lots of meds and mental treatment.
Like I said,been on SGLB from the start,going to stay till the FAT LADY SINGS.If you find another co. that has this much going on at these prices let me know.3-d printing is here to stay and SGLB has a good foot in the front door.Strong BUY.Have a Great Weekend.
SGLB,is at the top of there game,GE wants in,Boeing needs them,dont be fooled. By FOOLS.
Many are not going to be able to resist and hit sell,when it really starts to fly. The ones who can hold,will be very rich.SGLB,has what others want,and will not let there life work go for cheap.There are only a few times in a lifetime to make the big score, for most.This is one of them.Dont blow it.This is not your normal penny stock.This one has legs and GE and Boeing are going to be there feet.Good luck to all.Dont forget the sick and hungry.
Hea,I guess your right.When do think any of the big funds will jump in,or do they have rules from above,not to buy,till its over a dollar or so.?
Weak hands will be sorry,when the big boys see,I mean investors, how important SGLB is,and the money that can be saved,by useing there tec.Ge and Boeing know what there getting into. SGLB will be a house hold name in 3-d printing.Not to miss out on what else they have in store.pretty smart people in SGLB,coming up with some great changes in how we make things.China will be trying to get this info soon,there already bitting at there fingers,they know what this will mean.For once again USA will hold the ACE.Go AMERICA.
Thanks,for your understanding,it was painful,I had my doubts many times. Sold some at .045 months ago,wish i didnt,now.Still holding over 100k,at a good price,Time will tell,I think we have a winner here,when the News starts to roll out,about how important SGLB work really is, hang on.Going to be a wild ride,I hope.
I have been watching SGLB,for 3 years,now.I have been telling people,about them,and no one seemed to care,till now.They are the real deal,glad i got in,when I did.Never seen any pumping on this stock.I paid .15 for some,.07,then when it below a penny,picked up a good amount.good to be in the GREEN for a change.Best of luck to all,A Great investment.
SGLB is one of the only penny stocks,that should not be a penny.I have been waiting a long time to see the fruit of their labor.Looks like it has come.Time is on our side.SGLB is a winner.Good trading to All.
Yes this seems a little crazy,this is Great News,and here we sit.The whole market seems to be held down except for a few,and even they slide back without really holding ground.The Rich really do control all the money.SGLB I think will shine,when ?.Time will tell.Best of luck to all.
Time bomb,SGLB is.The only penny stock I see that has the interest of large CO.really working with it.Our time will come I think.There working on some pretty important things.
GLER needs some news,tell us what they have in store for 2012.
That would be Great.GLER is always on to something new,thats what I like about this co.Keep the motor running.
If I buy in at .005 again,get my million shares back,then wait for a R/S I will have 4000 shares,and then get 3 for 1,cant wait.By the end of 2012,if we are all here I can buy enough rope do do the job.
Where is all the ifxy cheerleaders,hope everyone is ok.This has become a very big let down,to see all this time and peoples money go down the toilet.They should a least tell the truth about what really is going on.To keep putting out PR.and leading good people to belive there going places is a real let down.
IFXY is turning in into a sub penny again.This co. could not unclog a toilet,let a lone protect national security.Why I thought they had a chance ? Should hav sold when I saw their office.
SSOL has the tec and contracts to make money,just around the conner.A buyout is also not out.
They need to make some cash too,think they can sit around and not try to make another deal.NO GLER is a sleeper play,it will get going.
I knew this one was not out yet,GLER is the right spot,biofuels is there concern also,they got something up.Wait and see.
SGLB Patent on New Manufacturing Technology.
SGLB Patent on New Manufacturing Technology.
I think,we will see some big moves in the next few weeks,I think it will move up little at first than bamm,to the moon.A buyout could happen on this one.Fingers crossed.